< Back to previous page

Publication

Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant

Journal Contribution - Journal Article

Journal: NPJ VACCINES

ISSN: 2059-0105

Issue: 1

Volume: 5

Publication year:2020

Handle: http://hdl.handle.net/1854/LU-8671043
WoS Id: 000551518300001
DOI: https://doi.org/10.1038/s41541-020-00211-5

Accessibility:Open

See also: Specific targeting of IL-1ß activity to CD8+ T cells allows for safe use as a vaccine adjuvant.